Related Tags >> cystic fibrosis FDA Genentech Avian Flu

Pharmaxis News

Most Popular Pharmaxis Story

ALSO NOTED: Pharmaxis touts late-stage study; ALS gains orphan drug status; H5N1 passed human-to-human; and much more...

August 29, 2007 — 6:59am ET

> Pharmaxis says that a late-stage study of its experimental drug for a chronic lung condition demonstrated its effectiveness. Read more...

Pharmaxis Press Releases

PRESS RELEASE: Phase III Trial Finds Pharmaxis's Bronchitol Effective; Two Primary Efficacy Endpoints Met

Latest Headlines

ALSO NOTED: Pharmaxis reports Phase II CF data; New Zealand publishes biotech industry stats; and much more...
April 4, 2008
ALSO NOTED: Pharmaxis touts late-stage study; ALS gains orphan drug status; H5N1 passed human-to-human; and much more...
August 29, 2007
ALSO NOTED: Bronchitol gains fast track; Alimera garners $15.9M in second tranche; and much more...
November 26, 2006
C&L: SciClone Pharmaceuticals' COO resigns
November 21, 2006
ALSO NOTED: Pharmaxis drug gains fast track status; EC approves UCB/Schwarz acquisition; and much more...
November 21, 2006
ALSO NOTED: Sanofi to shrink sales force; Santarus to add sales reps; and much more...
October 24, 2006
ALSO NOTED: Pharmaxis launches Phase III Bronchitol trial; TeGenero offers trial settlement; and much more...
April 18, 2006
Australian regulators OK new asthma test
March 22, 2006
ALSO NOTED: Vasogen to complete Phase III trials this year; Viventia to go private; and much more...
November 13, 2005
ALSO NOTED: ISTO wraps financing deal; Chiron facility found acceptable; Pharmaxis trial hits endpoint; and much more...
August 30, 2005
ALSO NOTED: British stock vaccine; Epix sees trial delay; BioDelivery gains $7M; Ranbaxy in marketing talks; and much more...
July 19, 2005

Paid Research Reports